PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Lab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizon

Swansea University

2025-08-11
(Press-News.org) Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.

The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid — structures that viruses often target to begin infection. By copying this structure, the synthetic molecule acts as a decoy, binding to the virus’s spike protein and preventing it from attaching to real cells.

Unlike vaccines, which trigger immune responses, this molecule acts as a physical shield, offering a novel approach to infection prevention.

Using advanced lab techniques to measure molecular interactions and simulate virus binding, researchers found that the glycosystem binds to the virus 500 times more strongly than a similar compound containing sulphates but no sugars. It was also effective at very low doses and worked against both the original SARS-CoV-2 strain and the more infectious D614G variant.

Tests on human lung cells showed a 98.6% reduction in infection when the molecule was present. Crucially, the research highlighted that its effectiveness stems not just from its charge, but from its precise sugar structure — giving this glycosystem its powerful infection-blocking capability.

The discovery is the result of collaboration between Swansea University, Freie Universität Berlin, and Charité – Universitätsmedizin Berlin.

As the main corresponding author and research supervisor, Dr Sumati Bhatia, Senior Lecturer in Chemistry at Swansea University, said: “Leading this research, alongside our international partners, has been incredibly rewarding. It opens a new direction for using glycosystems as a therapeutic strategy against SARS-CoV-2 and could lay the foundation for a new class of antiviral therapies to protect those most at risk.”

The team is now preparing for further biological testing in high-containment laboratories to assess the molecule’s effectiveness against multiple virus strains.

This breakthrough could pave the way for antiviral nasal sprays, surface disinfectants, and treatments to protect vulnerable groups, offering a new line of defence against Covid-19 and future pandemics.

Read the full study: “Polysialosides Outperform Sulfated Analogues for Binding with SARS‐CoV‐2.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Rice’s dean of engineering and computing building new software infrastructure for evolutionary biology

2025-08-11
Rice University computer scientist Luay Nakhleh, who also serves as the dean of the George R. Brown School of Engineering and Computing, has received a $1.9 million grant from the National Science Foundation to build a powerful new software infrastructure that could significantly expand how scientists study evolution. The project, titled PhyNetPy, aims to bring the next generation of evolutionary modeling tools into the hands of researchers around the world by enabling the widespread use of phylogenetic networks — complex, ...

Researchers discover all-new antifungal drug candidate in McMaster’s greenhouse

2025-08-11
A research team at McMaster University has discovered a new drug class that could someday lead to breakthrough treatments for dangerous fungal infections. The new molecules, dubbed coniotins, were isolated from a plant-dwelling fungus called Coniochaeta hoffmannii — the samples of which were collected from the McMaster greenhouse, located on the university’s campus. Detailed recently in the journal Nature Communications, the discovery responds to a critical need for new antifungal medicines.    “There is a huge, growing clinical need for new drugs that target fungal infections,” says Gerry Wright, a ...

New quality control for ‘wonder material’ graphene oxide is cheapest and fastest yet

2025-08-11
Scientists have created new way to characterise graphene oxide (GO) cheaper and quicker than ever before, helping get the emerging technology out of the lab and into the market.  Researchers at King’s College London have designed an ‘interactional fingerprinting’ method that creates a unique identity of individual samples. By mimicking humans’ sense of taste and smell, the method can create a qualitative snapshot of the material without relying on inaccessible gold-standard measurement machinery manned by teams of specialists.   By promising a faster and cheaper way to quality control graphene oxide, the scientists ...

How organic matter traps water in soil — even in the driest conditions

2025-08-11
From lifelong farmers to backyard gardeners, most plant-lovers know that adding organic matter to a field, vegetable plot or flowerpot increases the soil’s moisture. Now, for the first time, Northwestern University scientists have uncovered the molecular mechanisms that enable organic matter to boost soil’s ability to retain water — even in desert-like conditions. Carbohydrates — key components of plants and microbes — act like a molecular glue, using water to form sticky bridges between organic molecules and soil minerals, the team found. These bridges lock in moisture that ...

Cancer center taps UTA expert for survivor health study

2025-08-11
A researcher at The University of Texas at Arlington is helping a leading national cancer center explore how wearable devices could help childhood cancer survivors avoid long-term health complications such as diabetes and heart disease. Yue Liao, assistant professor of kinesiology at UT Arlington, was invited by researchers at City of Hope, a National Cancer Institute-designated comprehensive cancer center, to contribute to a review article published in Cancer. The article examines how survivors of childhood cancer face elevated risks of chronic conditions such as diabetes and how digital health tools could help detect—and possibly prevent—these ...

Big gains in type 1 diabetes glucose-control management in recent years

2025-08-11
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found big increases in the use of continuous glucose monitoring and insulin delivery devices by children and adults with type 1 diabetes over a 15-year period, with corresponding jumps in optimal blood-sugar control. For their study, the researchers used a large national database of de-identified electronic health records to analyze nearly 200,000 individuals with type 1 diabetes across five three-year periods from 2009 to 2023. The research team tracked individuals’ adoption of continuous ...

Researchers unlock safer RNA therapies for inflammatory diseases

2025-08-11
PHILADELPHIA – Lipid nanoparticles (LNPs) are tiny fat bubbles that are used to deliver medicines, genes, and RNA into cells. However, in some cases LNPs can cause harmful inflammation as a result of the process of RNA delivery. Now, two new solutions can help alleviate inflammation while still getting RNA where it needs to be in the cell. One discovery found that inflammation could be reduced with the addition of a unique biodegradable lipid to the treatment; another solution identified a common drug, called thiodigalactoside (TG), which blocked inflammation when added to the LNP. Today’s Nature Nanotechnology features this research from the Perelman ...

New gene linked to aggressive, treatment-resistant prostate cancer

2025-08-11
“These findings highlight that, in PC, RSPO2 functions as a unique member of the R-spondin family by promoting genes and signaling pathways associated with aggressive PC, and RSPO2 amplifications are associated with poor outcomes in PC patients.” BUFFALO, NY – August 11, 2025 – A new research paper was published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer.” In this study, researchers led by first ...

Why oxytocin treatments for social behavior are inconsistent

2025-08-11
Oxytocin promotes social behaviors and helps maintain relationships. But clinical trials in patients with autism show variability in how consistently oxytocin improves these behaviors. Steve Chang, from Yale University, led a study to explore how oxytocin influences brain activity to shape social behavior in rhesus monkeys and why its effects are so variable. This work is featured in JNeurosci’s Central Questions for Social Neuroscience Research Special Collection.  The researchers focused on the basolateral amygdala (BLA) and the anterior cingulate cortex (ACC) because these brain areas process reward and integrate ...

The ISSCR releases targeted update to the guidelines for stem cell research and clinical translation

2025-08-11
The International Society for Stem Cell Research (ISSCR) released an update of its 2021 Guidelines for Stem Cell Research and Clinical Translation today. The targeted update addresses significant advances in the development and application of human stem cell-based embryo models (SCBEMs) and recommendations for research oversight outlined in a white paper from the ISSCR Embryo Models Working Group published in June. SCBEMs are three-dimensional stem cell-derived structures that replicate key aspects of early embryonic development. ...

LAST 30 PRESS RELEASES:

Drones reveal unexpectedly high emissions from wastewater treatment plants

Dancing alleviated perceived symptoms of depression and helped to understand its root causes

Tricky treats: Why pumpkins accumulate pollutants

Revealing the molecular structures of sugars using galectin-10 protein crystals

World’s leading medical journal details the climate emergency

GLP-1 drugs effective for weight loss, but more independent studies needed

Researchers uncover previously unexplored details of mosquito’s specialized detection mechanisms

Stem cell therapy linked to lower risk of heart failure after a heart attack

The NHS is reaching a crisis point in consultant recruitment, new report warns

UNM research suggests Halloween fireballs could signal increased risk of cosmic impact or airburst in 2032 and 2036

Biochar’s hidden helper: Dissolved organic matter boosts lead removal from polluted water

Sunlight turns everyday fabrics into ocean microfibers, new study finds

Antibiotics linked to lower risk of complications after obstetric tear

Rapid blood pressure fluctuations linked to early signs of brain degeneration in older adults

How microbes control mammalian cell growth

Emergency department pilot program serves rural families

Amid renewable-energy boom, study explores options for electricity market

Study finds improvement in knee pain with exercise and physical therapy

Researchers uncover key mechanism behind chemotherapy-induced nerve damage

Mayo Clinic researchers find enhancing the body’s ‘first responder’ cells may boost immune therapy for cancer

Secret to a long life? In bowhead whales, a protein repairs damaged DNA

MIT study: Identifying kids who need help learning to read isn’t as easy as A, B, C

Plant biomass substance helps combat weeds

Veterans with epilepsy after traumatic brain injury may have higher mortality rates

Who is more likely to lose vision due to high brain pressure?

Scripps Research professor awarded $3.2 million to advance type 1 diabetes research

Anna Wuttig wins Bayer Foundation Early Excellence in Science Award

Electric vehicles outperform gasoline cars in lifetime environmental impact

Kilimanjaro has lost 75 percent of its natural plant species over the last century

Spider web “decorations” may help pinpoint location of captured prey

[Press-News.org] Lab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizon
Swansea University